Drug testing in the patient: Toward personalized cancer treatment

See allHide authors and affiliations

Science Translational Medicine  22 Apr 2015:
Vol. 7, Issue 284, pp. 284ps10
DOI: 10.1126/scitranslmed.aab1214

You are currently viewing the abstract.

View Full Text


Two different devices show that delivery of cancer drugs directly into tumors in vivo can indicate cancer sensitivity; if implemented in clinical practice, these devices have the potential to reduce indiscriminate drug use, to improve survival, and to reduce unnecessary adverse effects (Jonas et al. and Klinghoffer et al., this issue).

View Full Text